Ohio Medicaid Restrictions on GLP-1 Drug Coverage for Obesity
What happened
Ohio Department of Medicaid is prohibited from covering GLP-1 medications for obesity in adults due to a restriction in the Ohio administrative code. While the department does cover certain GLP-1 medications for other conditions, such as type 2 diabetes or cardiovascular risk reduction, coverage is excluded for adult obesity. However, Ohio Medicaid does provide coverage for adolescents under 18 due to federal guidelines.
Why it matters
The restriction impacts the availability of GLP-1 medications, which the National Institutes of Health found effective for chronic weight management. A national organization is currently advocating for state officials to change the administrative code.
Who's involved
- OhioState whose administrative code restricts Medicaid coverage of GLP-1 medications
- National Institutes of HealthGovernment agency that provided scientific backing for GLP-1 effectiveness
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- OhioSpeculative
Individuals with obesity might face higher out-of-pocket costs for GLP-1 medications if the administrative code remains unchanged
Keep exploring
The entities involved
- FDA
-
Ohio
state of the United States of America
-
National Institutes of Health
government organization in Shah Alam, Malaysia
Related events
- AMA urges FDA to maintain standards as federal government implements marijuana rescheduling order amid GAO findings of regulatory deficiencies.
- FDA approved a medical device from Abbott and supported a PARADIGM study based on data from the Cleveland Clinic.
- FDA placed a clinical hold on the drug application submitted by Bright Minds Biosciences Inc.
- FDA reviewed an NDA and entered a clinical study agreement for a babesiosis trial involving 60 Degrees Pharmaceuticals.
- Discussion on the limits of pharmacotherapy and the role of FDA approvals.